The results indicated that DNAI2 was increased in the early stage of NSCLC but was decreased in the late stage, indicating that DNAI2 might be involved in lung tumorigenesis (Fig. 7A). The gene discussed is DNAI2; the disease is non-small cell lung carcinoma.